SCHEMBL1502177

SCHEMBL1502177

COc1nc(N)c(Cl)cc1C(=O)NCC1CNCCO1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 5/20 0.44
HTR4 Q13639 2/20 0.44
DRD2 P14416 1/20 0.43
KDM4E B2RXH2 2/20 0.41
SLC6A2 P23975 3/20 0.39
SLC6A4 P31645 3/20 0.39
HPGD P15428 2/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KMT2A Q03164 1/20 0.39
SLC6A3 Q01959 2/20 0.38
HTR3A P46098 1/20 0.38
CHEK2 O96017 1/20 0.38
NTRK1 P04629 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1501974 0.88 CHEK1 (0.44) CHEK1KDM4EHPGDALDH1A1GAA
SCHEMBL1501969 0.82 HTR4 (0.66) HTR4DRD2KDM4EALDH1A1HTR3A
Hydrochloric Acid SCHEMBL9021789 0.81 HTR4 (0.65) HTR4DRD2KDM4EHTR3A
SCHEMBL6329778 0.81 HTR4 (0.67) HTR4DRD2HTR3A
SCHEMBL7991765 0.77 HTR4 (0.64) HTR4DRD2KDM4EHTR3A
SCHEMBL1501979 0.77 HTR1A (0.60) CHEK1HTR4DRD2KDM4ESLC6A2
SCHEMBL1502205 0.76 HTR4 (0.52) CHEK1HTR4DRD2SLC6A4KMT2A
SCHEMBL1502383 0.76 HPGD (0.53) CHEK1HTR4KDM4EHPGDALDH1A1
SCHEMBL1753594 0.76 MKNK2 (0.50) CHEK1KDM4EHPGDALDH1A1GAA
SCHEMBL1502088 0.75 LMNA (0.52) CHEK1HTR4DRD2SLC6A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256114-B1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAINIPPON SUMITOMO PHARMA CO (JP) 2014-06-25 EP disclosed
US-7906510-B2 Amide derivative and pharmaceutical composition containing the same Dainippon Sumito Pharma Co., Ltd. (JP) 2011-03-15 US disclosed
EP-2256114-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Dainippon Sumitomo Pharma Co., Ltd. (JP) 2010-12-01 EP disclosed
US-20100249399-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Sumitomo Pharma Co., Ltd. (JP) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249399-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME HTR4, MC2R, HTR1D CHEK1 4582/4885HTR4 1/4885DRD2 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.